Ignite Creation Date:
2025-12-25 @ 12:52 AM
Ignite Modification Date:
2026-01-05 @ 5:50 PM
Study NCT ID:
NCT05269667
Status:
TERMINATED
Last Update Posted:
2025-01-22
First Post:
2022-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
Sponsor:
Hoffmann-La Roche
Organization: